Newsfeeds - Spark Newswire

5 minute read

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera’s COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold

Today, 7:02 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16)

ABCL

5 minute read

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study

By Shanthi Rexaline

Today, 7:02 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15)

ACHL

4 minute read

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test

By Shanthi Rexaline

Today, 7:02 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9)

ABSI

2 minute read

Earnings

Bicycle Therapeutics Earnings Perspective: Return On Capital Employed

By Benzinga Insights

Today, 7:02 AM

Bicycle Therapeutics (NASDAQ:BCYC) brought in sales totaling $1.78 million during Q2 according to data provided by Benzinga Pro.However, earnings decreased 7.82%, resulting in a loss of $17.28 million.

BCYC

3 minute read

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself

By Shanthi Rexaline

Today, 7:02 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2)

ABT

5 minute read

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab

By Shanthi Rexaline

Today, 7:02 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1)

ABBV

5 minute read

60 Biggest Movers From Yesterday

By Lisa Levin

Today, 7:02 AM

Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.

ABVC

1 minute read

Bicycle Therapeutics Q2 EPS $(0.74) Down From $(0.67) YoY, Sales $1.78M Up From $1.57M YoY

By Benzinga Newsdesk

Today, 7:02 AM

Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.74) per share. This is a 10.45 percent decrease over losses of $(0.67) per share from the same period last year. The company reported $1.78 million in

BCYC